MANCHESTER, England--(BUSINESS WIRE)--Synexus, which confidently expects to sign a record amount of new business this year, has expanded its therapeutic offering to its global pharma and CROs clients and further strengthened its board. UK based Synexus is the largest multinational organisation dedicated to the recruitment of patients and running of clinical trials at its own Dedicated Research Centres across the world.
